{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T10:15:36Z","timestamp":1788257736927,"version":"build-2803163510"},"reference-count":60,"publisher":"Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:p>Background: Oral lichen planus (OLP) is a chronic inflammatory disease associated with oral microbiome imbalance and immune dysregulation. Objectives: To evaluate the effects of CPC mouthwash combined with triamcinolone acetonide on oral microbiota and Th17\/Treg balance in erosive OLP patients. Methods: This study involved 80 patients with erosive OLP from January 2023 to January 2025. They were divided into: A control group treated with triamcinolone acetonide and a combination group treated with triamcinolone acetonide plus cetylpyridinium chloride mouthwash. After 4 weeks, primary outcomes included clinical efficacy, visual analog scale (VAS) pain scores, changes in signs and erosive area, oral salivary bacteria detection rate, Th17\/Treg ratio, serum adipokine chemerin and cytokine levels (IL-17, TNF-?, IL-10) and OHIP-14 scores. Secondary outcomes were adverse reaction incidence and recurrence rates during follow-up. Results: The combination group showed better outcomes after 4 weeks of treatment. The total effective rate was 95%, higher than the control group's 80% (P=0.022). The combination group had superior pain relief (P=0.024), better mucosal repair (P=0.002) and a significant decrease in erosive area (P=0.021). It also had lower oral detection rates of Staphylococcus and Candida albicans (P&lt;0.05). Immunologically, the combination therapy significantly reduced serum levels of chemerin, Th17 cells, Th17\/Treg ratio, IL-17 and TNF-? (P&lt;0.001), while increasing Treg cells and IL-10 levels (P=0.003), indicating stronger anti-inflammatory and immune-balancing effects. The combination group showed a greater reduction in the OHIP-14 score (P &lt; 0.001), indicating improved oral health-related quality of life. No significant difference in adverse reactions was observed (P&gt;0.05) and all were mild. The combination group had a lower recurrence rate within 3 months post-treatment, although the difference was not statistically significant (P=0.521). Conclusion: The combination of cetylpyridinium chloride mouthwash with triamcinolone acetonide effectively regulates the oral microbiota structure and restores the Th17\/Treg immune balance in OLP patients.<\/jats:p>","DOI":"10.36721\/pjps.2026.39.6.162.1","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T12:40:56Z","timestamp":1775306456000},"source":"Crossref","is-referenced-by-count":0,"title":["The Effects Of Cetylpyridinium Chloride Mouthwash Combined With Triamcinolone Acetonide On Oral Microbiota And The Th17\/Treg Balance In Patients With Oral Lichen Planus"],"prefix":"10.36721","author":[{"given":"Lingshan","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22735","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Abdelsamie M, Zahran F, Hussine AA, Shaker O and Al-Mahallawi AM (2023). Clinical and biochemical assessment of the effect of topical use of coenzyme Q10 versus topical corticosteroid in management of symptomatic oral lichen planus: Randomized controlled clinical trial. BMC Oral Health, 23(1): 506.","DOI":"10.1186\/s12903-023-03206-5"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Alam J, Lee A, Lee J, Kwon DI, Park HK, Park JH, Jeon S, Baek K, Lee J, Park SH and Choi Y (2020). Dysbiotic oral microbiota and infected salivary glands in Sjogren's syndrome. PLoS One, 15(3): e0230667.","DOI":"10.1371\/journal.pone.0230667"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Alhallak M, Karpukhina N and Patel M (2024). Permeability of triamcinolone acetonide, released from mucoadhesive films, through a buccal mucosa-mimetic barrier: Permeapad\u2122. Dent Mater, 40(9): 1372-1377.","DOI":"10.1016\/j.dental.2024.06.016"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Ardizzoni A, Pericolini E, Paulone S, Orsi CF, Castagnoli A, Oliva I, Strozzi E and Blasi E (2018). In-vitro effects of commercial mouthwashes on several virulence traits of Candida albicans, viridans streptococci and Enterococcus faecalis colonizing the oral cavity. PLoS One, 13(11): e0207262.","DOI":"10.1371\/journal.pone.0207262"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Baek K, Lee J, Lee A, Lee J, Yoon HJ, Park HK, Chun J and Choi Y (2020). Characterization of intratissue bacterial communities and isolation of Escherichia coli from oral lichen planus lesions. Sci Rep, 10(1): 3495.","DOI":"10.1038\/s41598-020-60449-w"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Bakhshi M, Gholami S, Mahboubi A, Jaafari MR and Namdari M (2020). Combination therapy with 1% nanocurcumin Gel and 0.1% triamcinolone acetonide mouth rinse for oral lichen planus: A randomized double-blind placebo controlled clinical trial. Dermatol Res Pract, 2020: 4298193.","DOI":"10.1155\/2020\/4298193"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Bloch S, Hager-Mair FF andrukhov O and Schaffer C (2024). Oral streptococci: Modulators of health and disease. Front Cell Infect Microbiol, 14: 1357631.","DOI":"10.3389\/fcimb.2024.1357631"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Brookes Z, Teoh L, Cieplik F and Kumar P (2023). Mouthwash effects on the oral microbiome: Are they good, bad, or balanced? Int Dent J, 73(Suppl 2): S74-s81.","DOI":"10.1016\/j.identj.2023.08.010"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Chaitanya NC, Chikte D, Kumar YP, Komali G, Yellarthi SP, Reddy CS, Harika DP, Haritha S, Taie WAA, Hatab NA, Patil S and Panta P (2022). Efficacy of spirulina 500 mg vs triamcinolone acetonide 0.1% for the treatment of oral lichen planus: A randomized clinical trial. J Contemp Dent Pract, 23(5): 552-557.","DOI":"10.5005\/jp-journals-10024-3299"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Daume L, Kreis C, Bohner L, Kleinheinz J and Jung S (2020). Does the clinical form of oral lichen planus (OLP) influence the oral health-related quality of life (OHRQoL)? Int J Environ Res Public Health, 17(18): 6633.","DOI":"10.3390\/ijerph17186633"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"De Porras-Carrique T, Ramos-Garcia P, Aguilar-Diosdado M, Warnakulasuriya S and Gonzalez-Moles M (2023). Autoimmune disorders in oral lichen planus: A systematic review and meta-analysis. Oral Dis, 29(4): 1382-1394.","DOI":"10.1111\/odi.14127"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Deng S, Xu Y, Wang X, Liu M, Li L, Yu X, Wang Y, Wu Y, Wang W, Gao M and Cong B (2020). Study on the role of salivary flora and NF-\u03baB inflammatory signal pathway in oral lichen planus. Inflammation, 43(3): 994-1008.","DOI":"10.1007\/s10753-020-01185-1"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Deng X, Wang Y, Jiang L, Li J and Chen Q (2022). Updates on immunological mechanistic insights and targeting of the oral lichen planus microenvironment. Front Immunol, 13: 1023213.","DOI":"10.3389\/fimmu.2022.1023213"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Dey I and Bishayi B (2017). Role of Th17 and Treg cells in septic arthritis and the impact of the Th17\/Treg -derived cytokines in the pathogenesis of S. aureus induced septic arthritis in mice. Microb Pathog, 113: 248-264.","DOI":"10.1016\/j.micpath.2017.10.033"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"El-Howati A, Thornhill MH, Colley HE and Murdoch C (2023). Immune mechanisms in oral lichen planus. Oral Dis, 29(4): 1400-1415.","DOI":"10.1111\/odi.14142"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Fantozzi PJ, Treister N, Shekar R, Woo SB and Villa A (2019). Intralesional triamcinolone acetonide therapy for inflammatory oral ulcers. Oral Surg Oral Med Oral Pathol Oral Radiol, 128(5): 485-490.","DOI":"10.1016\/j.oooo.2019.07.024"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Fernandes AR, Vidal LB, Sanchez-Lopez E, Dos Santos T, Granja PL, Silva AM, Garcia ML and Souto EB (2022). Customized cationic nanoemulsions loading triamcinolone acetonide for corneal neovascularization secondary to inflammatory processes. Int J Pharm, 623: 121938.","DOI":"10.1016\/j.ijpharm.2022.121938"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Moles M and Ramos-Garcia P (2023). Oral lichen planus and related lesions. What should we accept based on the available evidence? Oral Dis, 29(7): 2624-2637.","DOI":"10.1111\/odi.14438"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Gonzalez-Moles M, Warnakulasuriya S, Gonzalez-Ruiz I, Gonzalez-Ruiz L, Ayen A, Lenouvel D, Ruiz-Avila I and Ramos-Garcia P (2021). Worldwide prevalence of oral lichen planus: A systematic review and meta-analysis. Oral Dis, 27(4): 813-828.","DOI":"10.1111\/odi.13323"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez-Cabanyero C and Vonaesch P (2024). Ectopic colonization by oral bacteria as an emerging theme in health and disease. FEMS Microbiol Rev, 48(2): fuae012.","DOI":"10.1093\/femsre\/fuae012"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Hwang AS, Kechter JA, Do TH, Hughes AN, Zhang N, Li X, Bogle R, Brumfiel CM, Patel MH, Boudreaux B, Bhullar P, Nassir S, Yousif ML, Stockard AL, Leibovit-Reiben Z, Ogbaudu E, DiCaudo DJ, Fox J, Gharaee-Kermani M, Xing X, Zunich S, Branch E, Kahlenberg JM, Billi AC, Plazyo O, Tsoi LC, Pittelkow MR, Gudjonsson JE and Mangold AR (2024). Rapid response of lichen planus to baricitinib associated with suppression of cytotoxic CXCL13+CD8+ T cells. J Clin Invest, 135(2): e179436.","DOI":"10.1172\/JCI179436"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Jolehar M, Mohseni R and Farhadi S (2021). Correlation between WHO and modified WHO classification systems in the histopathologic diagnosis of oral lichen planus using intraobserver and interobserver variability. Int J Prev Med, 12: 126.","DOI":"10.4103\/ijpvm.IJPVM_566_18"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Kim N, Fischer AH, Dyring-Andersen B, Rosner B and Okoye GA (2017). Research techniques made simple: Choosing appropriate statistical methods for clinical research. J Invest Dermatol, 137(10): e173-e178.","DOI":"10.1016\/j.jid.2017.08.007"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Le Gatt P, Nguyen AT, Baaroun V and Rochefort J (2023). Oral lichen planus in patients with good's syndrome: A literature review. Cureus, 15(2): e35177.","DOI":"10.7759\/cureus.35177"},{"key":"ref24","unstructured":"LeBel G, Vaillancourt K, Morin MP and Grenier D (2020). Antimicrobial activity, biocompatibility and anti-inflammatory properties of cetylpyridinium chloride-based mouthwash containing sodium fluoride and xylitol: An in vitro study. Oral Health Prev Dent, 18(4): 1069-1076."},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Li BZ, Zhou HY, Guo B, Chen WJ, Tao JH, Cao NW, Chu XJ and Meng X (2020). Dysbiosis of oral microbiota is associated with systemic lupus erythematosus. Arch Oral Biol, 113: 104708.","DOI":"10.1016\/j.archoralbio.2020.104708"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Liu X, Chen L, Peng W, Deng H, Ni H, Tong H, Hu H, Wang S, Qian J, Liang A and Chen K (2024). Th17\/Treg balance: The bloom and wane in the pathophysiology of sepsis. Front Immunol, 15: 1356869.","DOI":"10.3389\/fimmu.2024.1356869"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Liu Z, Wang L, Ren S and Sun J (2025). Comparison of the effect of the pulsed Er: YAG laser and topical corticosteroid on erosive oral lichen planus: A randomized clinical controlled trial. Lasers Med Sci, 40(1): 180.","DOI":"10.1007\/s10103-025-04419-6"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Lodolo M, Gobbo M, Bussani R, Torelli L, Rupel K, Ottaviani G, Poropat A and Biasotto M (2023). Histopathology of oral lichen planus and oral lichenoid lesions: An exploratory cross-sectional study. Oral Dis, 29(3): 1259-1268.","DOI":"10.1111\/odi.14112"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Louisy A, Humbert E and Samimi M (2024). Oral lichen planus: An update on diagnosis and management. Am J Clin Dermatol, 25(1): 35-53.","DOI":"10.1007\/s40257-023-00814-3"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Lv S, Fan W and Fan B (2023). Enhanced in-vitro antibacterial effect against Enterococcus faecalis by using both low-dose cetylpyridinium chloride and silver ions. BMC Oral Health, 23(1): 299.","DOI":"10.1186\/s12903-023-02972-6"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Ma D, Yang X and Wang M (2024). Association between oral lichen planus and Candida albicans infection: A systematic review and meta-analysis. Am J Transl Res, 16(8): 3462-3471.","DOI":"10.62347\/WCDS1944"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Manchanda Y, Rathi SK, Joshi A and Das S (2024). Oral Lichen Planus: An updated review of etiopathogenesis, clinical presentation and management. Indian Dermatol Online J, 15(1): 8-23.","DOI":"10.4103\/idoj.idoj_652_22"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Mao X, Auer DL, Buchalla W, Hiller KA, Maisch T, Hellwig E, Al-Ahmad A and Cieplik F (2020). Cetylpyridinium chloride: Mechanism of action, antimicrobial efficacy in biofilms and potential risks of resistance. Antimicrob Agents Chemother, 64(8): e00576-20.","DOI":"10.1128\/AAC.00576-20"},{"key":"ref34","unstructured":"Mehdipour M, Taghavi Zenouz A, Bahramian A, Yazdani J, Pouralibaba F and Sadr K (2010). Comparison of the effect of mouthwashes with and without zinc and fluocinolone on the healing process of erosive oral lichen planus. J Dent Res Dent Clin Dent Prospects, 4(1): 25-28."},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Nukaly HY, Halawani IR, Alghamdi SMS, Alruwaili AG, Binhezaim A, Algahamdi RAA, Alzahrani RAJ, Alharamlah FSS, Aldumkh SHS, Alasqah HMA, Alamri A and Jfri A (2024). Oral lichen planus: A narrative review navigating etiologies, clinical manifestations, diagnostics and therapeutic approaches. J Clin Med, 13(17): 5280.","DOI":"10.3390\/jcm13175280"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Offen E and Allison JR (2022). What is the malignant transformation potential of oral lichen planus? Evid Based Dent, 23(1): 36-37.","DOI":"10.1038\/s41432-022-0240-4"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Pendleton N, Clague JE, Horan MA, Rabbitt PM, Jones M, Coward R, Lowe C and McInnes L (2004). Concordance of Cornell medical index self-reports to structured clinical assessment for the identification of physical health status. Arch Gerontol Geriatr, 38(3): 261-269.","DOI":"10.1016\/j.archger.2003.10.005"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Petruzzi M, Della Vella F, Squicciarini N, Lilli D, Campus G, Piazzolla G, Lucchese A and van der Waal I (2023). Diagnostic delay in autoimmune oral diseases. Oral Dis, 29(7): 2614-2623.","DOI":"10.1111\/odi.14480"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Rajendiran M, Trivedi HM, Chen D, Gajendrareddy P and Chen L (2021). Recent development of active ingredients in mouthwashes and toothpastes for periodontal diseases. Molecules, 26(7): 2001.","DOI":"10.3390\/molecules26072001"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Reeve MP, Vehvil\u00e4inen M, Luo S, Ritari J, Karjalainen J, Gracia-Tabuenca J, Mehtonen J, Padmanabhuni SS, Kolosov N, Artomov M, Siirtola H, Olilla HM, Graham D, Partanen J, Xavier RJ, Daly MJ, Ripatti S, Salo T and Siponen M (2024). Oral and non-oral lichen planus show genetic heterogeneity and differential risk for autoimmune disease and oral cancer. Am J Hum Genet, 111(6): 1047-1060.","DOI":"10.1016\/j.ajhg.2024.04.020"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Riveira-Munoz E, Garcia-Vidal E, Bano-Polo M, Leon R, Blanc V, Clotet B and Ballana E (2023). Cetylpyridinium chloride-containing mouthwashes show virucidal activity against herpes simplex virus type 1. Viruses, 15(7): 1433.","DOI":"10.3390\/v15071433"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Sahingur SE, Culshaw S and Zhang P (2024). Regulation of metabolism and inflammation: Links with oral and systemic health: Part 3-Emerging concepts from pathogenesis to therapy. Mol Oral Microbiol, 39(4): 153-155.","DOI":"10.1111\/omi.12476"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Salinas-Gilabert C, Gomez Garcia F, Galera Molero F, Pons-Fuster E, Vander Beken S and Lopez Jornet P (2022). Photodynamic therapy, photobiomodulation and acetonide triamcinolone 0.1% in the treatment of oral lichen planus: A randomized clinical trial. Pharmaceutics, 15(1): 30.","DOI":"10.3390\/pharmaceutics15010030"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Shalaby R, Nawawy ME, Selim K, Bahaa S, Refai SE, Maksoud AE, Sayed ME, Essawy A, Elshaer A, ElShaer M, Kamel MM and Gamil Y (2024). The role of vitamin D in amelioration of oral lichen planus and its effect on salivary and tissue IFN-\u03b3 level: A randomized clinical trial. BMC Oral Health, 24(1): 813.","DOI":"10.1186\/s12903-024-04239-0"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Stolte KN, Mesas-Fern\u00e1ndez A, Meier K, Klein EK, Dommisch H, Ghoreschi K and Solimani F (2024). TYK2 inhibition with deucravacitinib ameliorates erosive oral lichen planus. Exp Dermatol, 33(4): e15080.","DOI":"10.1111\/exd.15080"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Tekin B, Xie F and Lehman JS (2024). Lichen Planus: What is new in diagnosis and treatment? Am J Clin Dermatol, 25(5): 735-764.","DOI":"10.1007\/s40257-024-00878-9"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Vicic M, Hlaca N, Kastelan M, Brajac I, Sotosek V and Prpic Massari L (2023). Comprehensive insight into lichen planus immunopathogenesis. Int J Mol Sci, 24(3):","DOI":"10.3390\/ijms24033038"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Wang H, Zhou J, Guo X, Li Y, Duan L, Si X and Zhang L (2020). Use of glucocorticoids in the management of immunotherapy-related adverse effects. Thorac Cancer, 11(10): 3047-3052.","DOI":"10.1111\/1759-7714.13589"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Wang J, Yang J, Xia W, Zhang M, Tang H, Wang K, Zhou C, Qian L and Fan Y (2023). Escherichia coli enhances Th17\/Treg imbalance via TLR4\/NF-\u03baB signaling pathway in oral lichen planus. Int Immunopharmacol, 119: 110175.","DOI":"10.1016\/j.intimp.2023.110175"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Wang J, Yang J, Xia W, Zhang M, Tang H, Wang K, Zhou C, Qian L and Fan Y (2023). Escherichia coli enhances Th17\/Treg imbalance via TLR4\/NF-\u03baB signaling pathway in oral lichen planus. Int Immunopharmacol, 119: 110175.","DOI":"10.1016\/j.intimp.2023.110175"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Wang W, Wang M, Ahmed MMS, Zhao Y, Wu H, Musa M and Chen X (2022). FAM3B serves as a biomarker for the development and malignancy of oral lichen planus. Int J Gen Med, 15: 763-776.","DOI":"10.2147\/IJGM.S346617"},{"key":"ref52","unstructured":"Wang Y, Xu Y and Wang J (2025). Research progress on helper T cell-17 and interleukin-17 in oral lichen planus.  J Prev Treat Stomatol Dis, 33(2): 153-159."},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Weber J, Bonn EL, Auer DL, Kirschneck C, Buchalla W, Scholz KJ and Cieplik F (2023). Preprocedural mouthwashes for infection control in dentistry-an update. Clin Oral Investig, 27(Suppl 1): 33-44.","DOI":"10.1007\/s00784-023-04953-z"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Wu D, Liu X, Zhou T and Tan J (2023). The expression of Th17\/Treg in oral submucosal fibrosis carcinogenesis and the significance in the development of mucosal lesions. Cell Mol Biol (Noisy-le-grand), 69(9): 84-88.","DOI":"10.14715\/cmb\/2023.69.9.12"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Yang X, Zhan C, Cheng T, Huang M, Ge W, Zhang Y, Chen T, Lu Y, Cui ZK and Hou J (2023). Evaluation of the transdentinal capability of the intrinsic antibacterial cetylpyridinium chloride\/cholesterol sterosomes In-vitro and in vivo. Int Endod J, 56(2): 245-258.","DOI":"10.1111\/iej.13865"},{"key":"ref56","unstructured":"Yim IS, Zhang L, Lin I and Laronde DM (2024). Controversies regarding oral lichen planus and lichenoid-dysplastic lesions. Can J Dent Hyg, 58(2): 98-105."},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Zhao W, Lin D, Deng S, Wang S, Guo Y, Yang J, Shi X and Zhou H (2022). Synergistic efficacy of plaque control with intralesional triamcinolone acetonide injection on erosive non-gingival oral lichen planus: A randomized controlled clinical trial. Int J Environ Res Public Health, 19(21): 13787.","DOI":"10.3390\/ijerph192113787"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Zhong EF, Chang A, Stucky A, Chen X, Mundluru T, Khalifeh M and Sedghizadeh PP (2020). Genomic analysis of oral lichen planus and related oral microbiome pathogens. Pathogens, 9(11): 952.","DOI":"10.3390\/pathogens9110952"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"Zhu X, Li Y, Zhang X, Zhang P, Tian Q, Ma C and Shi C (2023). Combination of cetylpyridinium chloride and chlorhexidine acetate: A promising candidate for rapid killing of gram-positive\/gram-negative bacteria and fungi. Curr Microbiol, 80(3): 97.","DOI":"10.1007\/s00284-023-03198-z"}],"container-title":["Pakistan Journal of Pharmaceutical Sciences"],"original-title":[],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:38:29Z","timestamp":1788255509000},"score":1,"resource":{"primary":{"URL":"https:\/\/pjps.pk\/single-article?id=7765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":60,"URL":"https:\/\/doi.org\/10.36721\/pjps.2026.39.6.162.1","relation":{},"ISSN":["1011-601X","3105-9686"],"issn-type":[{"value":"1011-601X","type":"print"},{"value":"3105-9686","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]}}}